Arcadia Biosciences, Inc. (RKDA)
0.1648
-0.04
(-19.02%)
USD |
NASDAQ |
Oct 16, 16:00
0.1594
-0.01
(-3.28%)
After-Hours: 20:00
Arcadia Biosciences Profit Margin (Quarterly) : -434.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -434.2% |
| March 31, 2026 | -398.6% |
| December 31, 2025 | -148.3% |
| September 30, 2025 | 65.74% |
| June 30, 2025 | -306.4% |
| March 31, 2025 | |
| December 31, 2024 | -332.0% |
| September 30, 2024 | -76.90% |
| June 30, 2024 | |
| March 31, 2024 | -95.95% |
| December 31, 2023 | -58.17% |
| September 30, 2023 | -49.23% |
| June 30, 2023 | |
| March 31, 2023 | -747.0% |
| December 31, 2022 | -427.4% |
| September 30, 2022 | -145.7% |
| June 30, 2022 | -98.42% |
| March 31, 2022 | -143.2% |
| December 31, 2021 | -440.2% |
| September 30, 2021 | -119.4% |
| June 30, 2021 | -385.9% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | -2.28K% |
| Date | Value |
|---|---|
| June 30, 2020 | -3.52K% |
| March 31, 2020 | |
| December 31, 2019 | -1.52K% |
| September 30, 2019 | -3.62K% |
| June 30, 2019 | |
| March 31, 2019 | -7.98K% |
| December 31, 2018 | -145.5% |
| September 30, 2018 | |
| June 30, 2018 | -1.53K% |
| March 31, 2018 | -4.96K% |
| December 31, 2017 | -207.3% |
| September 30, 2017 | -768.3% |
| June 30, 2017 | -404.2% |
| March 31, 2017 | -414.1% |
| December 31, 2016 | -1.06K% |
| September 30, 2016 | -388.4% |
| June 30, 2016 | -631.2% |
| March 31, 2016 | -609.2% |
| December 31, 2015 | -286.6% |
| September 30, 2015 | -253.4% |
| June 30, 2015 | -257.1% |
| March 31, 2015 | -712.0% |
| December 31, 2014 | -71.05% |
| December 31, 2013 | -143.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -- |
| PMGC Holdings, Inc. | -226.5% |
| Archer-Daniels-Midland Co. | 4.02% |
| Alico, Inc. | 17.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -315.6% |
| Return on Assets | -163.0% |
| Return on Invested Capital | -315.4% |
| Gross Profit Margin (Quarterly) | 43.73% |
| Operating Margin (Quarterly) | -34.37% |
| Return on Net Operating Assets | -446.6% |